Skip to main content
. 2022 Jun 23;13:829759. doi: 10.3389/fphar.2022.829759

FIGURE 5.

FIGURE 5

Abemaciclib in combination with gilteritinib induces cell-cycle arrest at G2 phase in lung cancer cells (A,B) A549 and H1650 cells were treated by 1 μM abemaciclib, or 150 nM gilteritinib alone, or their combination for 24 h, and cell cycle was determined by flow cytometry (n = 3). **p < 0.001.